top of page
Job Interview

Job offers

 Bioinformatician (m/f/d) for Epigenetic Networks in Aging and Cancer -  The Helmholtz Institute for Biomedical Engineering - Institute for Stem Cell Biology 

image.png

The job posting is for a postdoctoral position (100% TV-L E13) starting from October 2026 and is initially limited to 2,5 years. 

Within the project “Transform-Me” (supported by the Else Kröner-Fresenius Stiftung), we are investigating how epigenetic changes, particularly DNA methylation patterns, are coordinated across the genome. We anticipate these modifications are coherently modified in trans within epigenetic networks. We want to identify modules and hubs that are co-regulated in aging, development, and particularly in malignant transformation. Furthermore, we aim to modulate these epigenetic networks by epigenetic editing. We are looking for a bioinformatician with a strong background in epigenetic characterization of cell preparations with focus on DNA methylation. We are integrating own and public EPIC Illumina Bead Chip datasets, RNA-seq, ATAC-seq, ChIP-seq, nanopore, and single cell DNAm sequencing datasets. 

 

For specific questions, please contact Prof. Wolfang Wagner.​​​

​

The application deadline for the advertised position GB-P-56328 is August 30, 2026.

Applications should be sent via online portal

​

Lab website 

More information on this advert here 

Job Interview

Job offers

Postdoctoral Position investigating senescence in prostate cancer
UMass Chan Medical School, USA

Umasschan.jpeg

A postdoctoral research position is available in the laboratory of Marcus Ruscetti, Ph.D. at the University of Massachusetts Chan Medical School in Worcester, MA, USA to work on an NIH R37 funded project investigating the contribution of oncogene-induced and age-related stromal senescence to prostate cancer onset and immune suppression using innovative mouse modeling and single cell/spatial transcriptomic approaches. Our long-term goal is to translate our basic understanding of how senescence biology regulates critical tumor-immune interactions into the development of novel senolytic strategies to treat cancer patients.

 

To apply, please send a cover letter and CV to Dr. Marcus Ruscetti by September 1 2026.​​​

 

Lab website 

More information on this advert here 

Get Social with yICSA

  • Facebook
  • Twitter
  • Instagram
  • Linkedin
  • Youtube

Get Social with ICSA

  • Facebook ICSA
  • Twitter ICSA
  • Instagram
  • LinkedIn ICSA
  • YouTube ICSA

© 2025 by ICSA. Proudly created with wix.com

bottom of page